ロード中...
HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
Cancer immunotherapy has emerged as a promising cancer treatment. However, the presence of immune-refractory tumor cells limits its clinical success by blocking amplification of anti-tumor immunity. Previously, we found that immune selection by immunotherapy drives the evolution of tumors toward mul...
保存先:
| 出版年: | Nat Commun |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6987099/ https://ncbi.nlm.nih.gov/pubmed/31992715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-019-14259-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|